Growing community of inventors

Montreal, Canada

Marie-Pierre Dube

Average Co-Inventor Count = 2.80

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 12

Marie-Pierre DubeJean-Claude Tardif (6 patents)Marie-Pierre DubeEric Joseph Niesor (3 patents)Marie-Pierre DubeRuchi Upmanyu (3 patents)Marie-Pierre DubeMark E Samuels (1 patent)Marie-Pierre DubeDuane Guernsey (1 patent)Marie-Pierre DubeAndrew C Orr (1 patent)Marie-Pierre DubeEric J Niesor (1 patent)Marie-Pierre DubeMarie-Pierre Dube (7 patents)Jean-Claude TardifJean-Claude Tardif (14 patents)Eric Joseph NiesorEric Joseph Niesor (19 patents)Ruchi UpmanyuRuchi Upmanyu (3 patents)Mark E SamuelsMark E Samuels (5 patents)Duane GuernseyDuane Guernsey (1 patent)Andrew C OrrAndrew C Orr (1 patent)Eric J NiesorEric J Niesor (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Hoffmann-la Roche Inc. (6 from 4,943 patents)

2. Genome Atlantic (1 from 2 patents)


7 patents:

1. 12371748 - Genetic markers for predicting responsiveness to therapy with HDL-raising or HDL mimicking agent

2. 11549142 - CETP inhibitors for therapeutic use

3. 11401554 - Genetic markers for predicting responsiveness to therapy with HDL-raising or HDL mimicking agent

4. 10711303 - CETP inhibitors for therapeutic use

5. 10584385 - Genetic markers for predicting responsiveness to therapy with HDL-raising or HDL mimicking agent

6. 9909178 - Dalcetrapib for therapeutic use

7. 8334369 - Mutations in human UBIAD1

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/11/2025
Loading…